Eczema Trial, Recruiting (NCT05098821)

Eczema Trial, Recruiting NCT05098821 Sponsor: Charite University, Berlin, Germany Condition: Eczema

Printed from Voxsanity (voxsanity.com.au) — NCT05098821 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Eczema

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 18 or older.
People who have been diagnosed with atopic dermatitis (a type of chronic skin condition causing itchy, inflamed skin) for at least one year.
People whose skin condition has not improved enough with creams or ointments applied directly to the skin.
People who are currently being treated with dupilumab (an injectable medication used for atopic dermatitis).

Who may not be able to join:

People under the age of 18.
People with a known or suspected allergy or reaction to dupilumab or any of its ingredients.
People with an active skin reaction caused by contact with an allergen or irritant, where that reaction could make it harder to accurately assess the severity of their atopic dermatitis.
People with severe inflammation of the eye surface (conjunctivitis) or eyelids (blepharitis).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05098821

Sponsor: Charite University, Berlin, Germany

Phase: Not Applicable

Status: Recruiting

Condition: Eczema

More information: https://clinicaltrials.gov/study/NCT05098821

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 18 or older.
People who have been diagnosed with atopic dermatitis (a type of chronic skin condition causing itchy, inflamed skin) for at least one year.
People whose skin condition has not improved enough with creams or ointments applied directly to the skin.
People who are currently being treated with dupilumab (an injectable medication used for atopic dermatitis).

Who may not be able to join:

People under the age of 18.
People with a known or suspected allergy or reaction to dupilumab or any of its ingredients.
People with an active skin reaction caused by contact with an allergen or irritant, where that reaction could make it harder to accurately assess the severity of their atopic dermatitis.
People with severe inflammation of the eye surface (conjunctivitis) or eyelids (blepharitis).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Charite University, Berlin, Germany

Registry

ClinicalTrials.gov

Start date

1 October 2019

Est. completion

31 December 2025

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Comparison of T-cell inflammatory markers

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov